Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 10, 2003, Pages 939-943

  Garnero, P ^a,b   Conrozier, T ^c   Christgau, S ^d   Mathieu, P ^c   Delmas, P D ^a   Vignon, E ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Synarc   (France)

^c Hopital Sud   (France)

^d NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; COLLAGEN TYPE 2; DEOXYPYRIDINOLINE;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HUMAN; JOINT CAVITY; MALE; OSTEOLYSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLLAGEN; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HIP JOINT; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PEPTIDES; PROSPECTIVE STUDIES;

EID: 0141427820     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.10.939     Document Type: Article

References (29)

1. Felson DT. Epidemiology of osteoarthritis. In: Brandt KF, Doherty M, Lohmander LJ, eds. Osteoarthritis. Oxford: Oxford University Press, 1998:13-22.
2. Ravaud P, Giraudeau B, Auleley G-R, Drape J-L, Rousselin B, Paolozzi L, et al. Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis. Ann Rheum Dis 1998;57:624-9.
3. Garnero P, Rousseau J-C, Delmas P. Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases. Arthritis Rheum 2000;43:953-61.
4. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage of type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin invest 1994;93:1722-32.
5. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenase in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
6. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage of type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
7. Downs JT, Lane CL, Nestor NB, McLellan TJ, Kelly MA, Karam GA, et al. Analyis of collagenase-cleavage of type II collagen using a neoepitope ELISA. J Immunol Methods 2001;247:25-34.
8. Moskowitz RW, Holderbaum D, Atley LM, Eyre DR. Type II C-telopeptide 2B4 epitope is a marker for cartilage degradation in familial osteoarthritis [abstract]. Arthritis Rheum 1998;41 (suppl 9):S352.
9. Christgau S, Garnero P, Fledelius C, Jensen T, Moniz M, Ensig M, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15.
10. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26.
11. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;44:2613-24.
12. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
13. Lequesne M, Ray G. La coxopathie destructrice rapide idiopathique. Rev Rhum 1989;56:115-19.
14. Conrozier T, Chappuis-Cellier C, Richard M, Mathieu P, Richard S, Vignon E. Increased serum C-reactive protein levels by immunonephelomertry in patients with rapidly destructive disease hip osteoarthritis. Rev Rhum (Engl Ed), 1988;65:759-65.
15. Conrozier T, Vignon E. Quantitative radiography in osteoarthritis computerized measurement of radiographic knee and hip joint space. Imaging techniques part I: traditional methods. Ballieres Clin Rheumatol 1996;10:429-33.
16. Lehmann HJ, Mouritzen U, Christgau S, Cloos PAC, Christiansen C. Effect of bisphosphonate on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 2002;61:530-3.
17. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49.
18. Szulc P, Marchand F, Duboeuf F, Delmas PD. Cross-sectional assessment of age-related bone loss in men: the MINOS Study. Bone 2000;26:123-9.
19. Lane NE, Nevitt MC, Genant HK, Hochberg MC. Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar spine degeneration. J Rheumatol 1993;20:1911-18.
20. Conrozier T, Tron AM, Balblanc JC, Mathieu P, Piperno M, Fitousi F, et al. Measurement of the hip joint space using computerized image analysis. Rev Rhum 1993;60:105-11.
21. Conrozier T, Lequesne M, Favret H, Taccoen A, Vignan M, Vignon E. Measurement of the radiological hip joint space width. An evaluation of various methods of measurement. Osteoarthritis Cart 2001;9:281-286.
22. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretian of pyridinium crosslinks: a new marker of bone resorption in metabolic: bone disease. Bone Miner 1990;8:87-96.
23. Seibel MJ, Duncan A, Robins, SP. Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989;16:964-70.
24. Thompson PW, Spector TD, James IT, Henderson E, Hart DJ. Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis. BMJ 1992;31:759-61.
25. Stewart A, Black A, Robins SP, Reid DM. Bone density and bone turnover in patients with osteoarthritis and osteoporosis. J Rheumatol 1999;26:622-6.
26. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary collagen excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-15.
27. Hellio le Graverand MP, Tron AM, Ichaa M, Dalland MC, Richard M, Uebelhart D, et al. Assessment of urinary hydroxypyridinium crosslink measurements in osteoarthritis. BMJ 1996;35:1091-5.
28. Conrozier T, Saxne T, San Sei Fran C, Mathieu P, Tron AM, Heinegard D, et al. Serum concentration of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1988;57:527-32.
29. Chevalier X, Conrozier T, Gehrmann M, Claudepierre P, Mathieu P, Unger S, et al. Tissue inhibitor of metalloproteases-1 (TIMP-1) serum level may predict progression of hip osteoarthritis. Osteoarthitis Cartilage 2001;9:300-7.